First Time Loading...

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 32.62 CNY -0.24% Market Closed
Updated: May 18, 2024

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Non-Reccuring Items Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Non-Reccuring Items Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Non-Reccuring Items
¥11.7m
CAGR 3-Years
57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Non-Reccuring Items
¥12.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Non-Reccuring Items
¥1.7m
CAGR 3-Years
-66%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Non-Reccuring Items
¥3.5m
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Non-Reccuring Items
¥11.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Non-Reccuring Items
¥146.4k
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Non-Reccuring Items?
Non-Reccuring Items
11.7m CNY

Based on the financial report for Mar 31, 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Non-Reccuring Items amounts to 11.7m CNY.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 3Y
57%

Over the last year, the Non-Reccuring Items growth was 1 018%. The average annual Non-Reccuring Items growth rates for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have been 57% over the past three years .